AMANDA CIELUCH: Open Payments
NPI 1659086205 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 77 payments from 15 companies in 2025. Trend: 2023 $383 · 2024 $577 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $268 |
| Novo Nordisk Inc | 15 | $193 |
| GlaxoSmithKline, LLC. | 10 | $161 |
| Lilly USA, LLC | 11 | $119 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Stryker Corporation | 1 | $60 |
| Dexcom, Inc. | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 6 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $30 |
Products named: Ozempic, MOUNJARO, TRELEGY ELLIPTA, CREON, AIRSUPRA, CLOTTRIEVER BOLD CATHETER, Dexcom G6 Transmitter, LINZESS.
Industry payments across SC — which companies pay providers there.
